Correspondence

Shingles vaccination programme: changes from September 2023 letter

Introduction of Shingrix® vaccine for the whole programme and expansion of eligible cohorts.

• From: UK Health Security Agency and NHS England
• Published: 4 July 2023

Applies to England

Documents

Introduction of Shingrix® vaccine for the whole programme and expansion of eligible cohorts letter

HTML

Immunocompetent patients: timeline for the phased implementation of the change to eligible age

PDF, 66 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

From 1 September 2023, all newly eligible individuals will be offered 2 doses of the non-live shingles vaccine Shingrix® instead of Zostavax® and eligibility for the immunocompromised and immunocompetent cohorts will change.

This letter provides further details and links to the supporting programme guidance and materials for health professionals who are responsible for commissioning and operationally delivering the programme.

Published 4 July 2023